NKGen Biotech, Inc.

Biological Products, (No Diagnostic Substances)·SANTA ANA, CA

CEO

Song Paul Y.

CFO

Graf James A

Financials

19 shown

Type	Period	Ended	Filed
10-Q	Q1 2025	3/31/25	1/20/26	→
10-K	FY 2024	12/31/24	10/8/25	→
10-Q	Q3 2024	9/30/24	3/4/25	→
10-Q	Q2 2024	6/30/24	9/12/24	→
10-Q	Q1 2024	3/31/24	5/20/24	→
10-K/A	FY 2023	12/31/23	4/29/24	→
↓

Earnings Releases (8-K)

1 shown

Filed	Period
11/14/23	Q4 FY2023	→

News (8-K)

79 shown

Filed	Type	Description
2/26/26	Agreement	Entry into a Material Definitive Agreement	→
2/5/26	Agreement	Entry into a Material Definitive Agreement	→
1/26/26	Agreement	Entry into a Material Definitive Agreement	→
1/16/26	Agreement	Entry into a Material Definitive Agreement	→
1/9/26	Agreement	Entry into a Material Definitive Agreement	→
9/29/25	Agreement	Entry into a Material Definitive Agreement	→
↓

Prospectuses & Registrations

21 shown

Filed	Form	Description
3/4/25	424B3	PROSPECTUS SUPPLEMENT	→
9/13/24	424B3	PROSPECTUS SUPPLEMENT	→
7/23/24	ARS	FORM ARS	→
7/10/24	424B3	424B3	→
6/27/24	S-1/A	REGISTRATION STATEMENT	→
5/13/24	S-1/A	REGISTRATION STATEMENT	→
↓

Filing History(270 filings)

TypeDateAccessionPeriodSize

8-K

Feb 26, 2026

0001213900-26-020876CURRENT REPORT

Feb 20, 2026

253.4 KB

8-K

Feb 5, 2026

0001213900-26-012879CURRENT REPORT

Jan 30, 2026

254.5 KB

8-K

Jan 26, 2026

0001213900-26-007794CURRENT REPORT

Jan 20, 2026

279.1 KB

10-Q

Jan 20, 2026

0001845459-26-00000310-Q

Mar 31, 2025

10.0 MB

8-K

Jan 16, 2026

0001213900-26-005260CURRENT REPORT

Jan 12, 2026

253.2 KB

8-K

Jan 9, 2026

0001213900-26-003030CURRENT REPORT

Jan 5, 2026

362.2 KB

10-K

Oct 8, 2025

0001845459-25-00000410-K

Dec 31, 2024

16.7 MB

8-K

Sep 29, 2025

0001213900-25-093062CURRENT REPORT

Sep 25, 2025

274.6 KB

8-K

Sep 24, 2025

0001213900-25-091112CURRENT REPORT

Sep 18, 2025

639.4 KB

8-K

Sep 9, 2025

0001213900-25-085858CURRENT REPORT

Sep 4, 2025

267.4 KB

8-K

Jul 17, 2025

0001213900-25-065162CURRENT REPORT

Jul 14, 2025

758.5 KB

25-NSE

Jul 17, 2025

0001354457-25-000685

—

4.7 KB

8-K

Jul 16, 2025

0001213900-25-064774CURRENT REPORT

Jul 14, 2025

662.7 KB

8-K

Jun 20, 2025

0001213900-25-055833CURRENT REPORT

Jun 18, 2025

238.6 KB

SCHEDULE 13D

Jun 2, 2025

0001104659-25-055326

—

23.2 KB

Jun 2, 2025

0001104659-25-055325OWNERSHIP DOCUMENT

May 27, 2025

10.7 KB

8-K

May 20, 2025

0001213900-25-045648CURRENT REPORT

May 14, 2025

619.5 KB

NT 10-Q

May 15, 2025

0001213900-25-044178NOTIFICATION OF LATE FILING

Mar 31, 2025

20.1 KB

SCHEDULE 13G/A

May 15, 2025

0001172661-25-002127

—

9.7 KB

SCHEDULE 13D

May 12, 2025

0001213900-25-042042

—

8.3 KB

8-K

May 8, 2025

0001213900-25-040810CURRENT REPORT

May 5, 2025

640.2 KB

May 7, 2025

0001213900-25-040627OWNERSHIP DOCUMENT

May 5, 2025

7.2 KB

8-K

May 1, 2025

0001213900-25-038427CURRENT REPORT

Apr 25, 2025

270.8 KB

8-K

Apr 22, 2025

0001213900-25-034184CURRENT REPORT

Apr 21, 2025

271.8 KB

NT 10-K

Mar 31, 2025

0001213900-25-026395NOTIFICATION OF LATE FILING

Dec 31, 2024

17.8 KB

25 filings shown

Filed	Form	Description
2/3/25	DEF 14A	DEF 14A	→
1/24/25	PRE 14A	PRE 14A	→
7/22/24	DEF 14A	DEF 14A	→
5/17/24	PRE 14A	PRE 14A	→
5/3/23	DEF 14A	DEF 14A	→
4/10/23	PRE 14A	PRE 14A	→
↓

NKGen Biotech, Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(270 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
6/2/25	4	OWNERSHIP DOCUMENT	→
5/7/25	4	OWNERSHIP DOCUMENT	→
12/26/24	4	4	→
12/23/24	4	4	→
12/10/24	4	4	→
12/10/24	4	4	→
↓

Filed	Form	Description
7/17/25	25-NSE	25-NSE	→
6/2/25	SCHEDULE 13D	SCHEDULE 13D	→
5/15/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
5/12/25	SCHEDULE 13D	SCHEDULE 13D	→
2/28/25	SCHEDULE 13G	SCHEDULE 13G	→
2/14/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
↓